Cargando…

Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients

Coronavirus disease 2019 is caused by severe acute respiratory syndrome-coronavirus-2 infection to which there is no community immunity. Patients admitted to ICUs have high mortality, with only supportive therapies available. Our aim was to profile plasma inflammatory analytes to help understand the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fraser, Douglas D., Cepinskas, Gediminas, Slessarev, Marat, Martin, Claudio, Daley, Mark, Miller, Michael R., O’Gorman, David B., Gill, Sean E., Patterson, Eric K., dos Santos, Claudia C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Original Clinical Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314329/ https://www.ncbi.nlm.nih.gov/pubmed/32696007 http://dx.doi.org/10.1097/CCE.0000000000000144

Ejemplares similares

Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2021)

Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers
por: Fraser, Douglas D., et al.
Publicado: (2020)

Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation
por: Fraser, Douglas D., et al.
Publicado: (2020)

Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2020)

Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation
por: Gill, Sean E., et al.
Publicado: (2020)

Novel plasma protein biomarkers from critically ill sepsis patients
por: Van Nynatten, Logan R., et al.
Publicado: (2022)

Critically Ill COVID-19 Patients Exhibit Anti-SARS-CoV-2 Serological Responses
por: Fraser, Douglas D., et al.
Publicado: (2021)

Endothelial Glycocalyx Degradation in Critical Illness and Injury
por: Patterson, Eric K., et al.
Publicado: (2022)

Case Report: Inflammation and Endothelial Injury Profiling of COVID-19 Pediatric Multisystem Inflammatory Syndrome (MIS-C)
por: Fraser, Douglas D., et al.
Publicado: (2021)

Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets
por: Slessarev, Marat, et al.
Publicado: (2020)

COVID‐19 plasma proteome reveals novel temporal and cell‐specific signatures for disease severity and high‐precision disease management
por: Iosef, Cristiana, et al.
Publicado: (2022)

Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients
por: Fraser, Douglas D., et al.
Publicado: (2022)

Effect of sedation with inhaled anaesthetics on cognitive and psychiatric outcomes in critically ill adults: a systematic review protocol
por: Cuninghame, Sean, et al.
Publicado: (2022)

Initial evaluation of extracorporeal immunomodulatory therapy for the treatment of critically ill COVID-19 infected patients
por: Lemoine, Sandrine, et al.
Publicado: (2022)

Frugal Innovation: Enabling Mechanical Ventilation During Coronavirus Disease 2019 Pandemic in Resource-Limited Settings
por: Dave, Chintan, et al.
Publicado: (2021)

Cerebral Blood Flow Deviations in Critically Ill Patients: Potential Insult Contributing to Ischemic and Hyperemic Injury
por: Slessarev, Marat, et al.
Publicado: (2021)

Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning
por: Patel, Maitray A., et al.
Publicado: (2023)

A Proteinase 3 Contribution to Juvenile Idiopathic Arthritis-Associated Cartilage Damage
por: Patterson, Eric K., et al.
Publicado: (2021)

What's new in critical illness and injury science? Convalescent plasma for coronavirus disease-2019 patients with severe or critical illness
por: Miller, Andrew Carl, et al.
Publicado: (2021)

Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients
por: Piagnerelli, Michaël, et al.
Publicado: (2020)

Carboxyhemoglobinemia in Critically Ill Coronavirus Disease 2019 Patients
por: Faisal, Hina, et al.
Publicado: (2021)

Immunothrombosis Biomarkers for Distinguishing Coronavirus Disease 2019 Patients From Noncoronavirus Disease Septic Patients With Pneumonia and for Predicting ICU Mortality
por: Cani, Erblin, et al.
Publicado: (2021)

Natural History of Cognitive Impairment in Critical Illness Survivors. A Systematic Review
por: Honarmand, Kimia, et al.
Publicado: (2020)

Ischemic and Hemorrhagic Stroke Among Critically Ill Patients With Coronavirus Disease 2019: An International Multicenter Coronavirus Disease 2019 Critical Care Consortium Study*
por: Cho, Sung-Min, et al.
Publicado: (2021)

Feasibility of a web-based neurocognitive battery for assessing cognitive function in critical illness survivors
por: Honarmand, Kimia, et al.
Publicado: (2019)

Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism
por: Patel, Maitray A., et al.
Publicado: (2022)

Safety and Efficacy of Bronchoscopy in Critically Ill Patients With Coronavirus Disease 2019
por: Chang, Stephanie H., et al.
Publicado: (2021)

Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019
por: Doyen, Denis, et al.
Publicado: (2021)

Secondary Bacterial Infections in Critical Ill Patients With Coronavirus Disease 2019
por: Fu, Yiqi, et al.
Publicado: (2020)

Perinatal outcomes in critically ill pregnant women with coronavirus disease 2019
por: Romagano, Matthew P., et al.
Publicado: (2020)

Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients
por: Dupont, Thibault, et al.
Publicado: (2021)

Beyond the ventilator: Rehabilitation for critically ill patients with coronavirus disease 2019
por: Tan, Sing Chee, et al.
Publicado: (2020)

Corticosteroids Utilization in the Management of Critically Ill Coronavirus Disease-2019 Pneumonia
por: Yang, Cheng, et al.
Publicado: (2022)

PNEUMOMEDIASTINUM IN A CRITICALLY ILL CORONAVIRUS DISEASE 2019 (COVID-19) PATIENT
por: Hayrabedian, Moses, et al.
Publicado: (2020)

Dexmedetomidine-Associated Hyperpyrexia in Three Critically Ill Patients With Coronavirus Disease 2019
por: Czepiel, Kathryn S., et al.
Publicado: (2020)

Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019
por: Khan, Sikandar H., et al.
Publicado: (2020)

Epidemiological and Clinical Characterization of Superinfections in Critically Ill Coronavirus Disease 2019 Patients
por: Signorini, Liana, et al.
Publicado: (2021)

Machine Learning Prediction of Death in Critically Ill Patients With Coronavirus Disease 2019
por: Churpek, Matthew M., et al.
Publicado: (2021)

Experience With Cardiology-Oriented Outcomes in Critically Ill Patients With Coronavirus Disease 2019
por: Connor-Schuler, Randi, et al.
Publicado: (2020)

Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol
por: Kovacevic, Mary P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_55fs6p91b4aje7hsiqj9i1759t